CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $34,252
- in 1 filing
Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-03-20 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −2,268 | 5,400 | ||
| 2008-03-20 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −1,437 | 3,963 | ||
| 2008-03-20 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −163 | 3,800 | ||
| 2008-03-20 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −900 | 2,900 | ||
| 2008-03-20 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −200 | 2,700 | ||
| 2008-03-20 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −700 | 2,000 | ||
| 2008-01-30 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion | +14,262 | $9.31 | $133K | 251,827 |
| 2008-01-30 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion | +10,738 | $9.31 | $100K | 262,565 |
| 2008-01-30 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion · Incentive Stock Option (right to buy) | −10,738 | 0 | ||
| 2008-01-30 | SKOLNICK MARK H Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −14,262 | 45,000 | ||
| 2008-01-25 | CRITCHFIELD GREGORY C President Myriad Genetic Labs | Exercise or conversion | +9,322 | $7.03 | $66K | 53,121 |
| 2008-01-25 | CRITCHFIELD GREGORY C President Myriad Genetic Labs | Exercise or conversion · Incentive Stock Option (right to buy) | −9,322 | 0 | ||
| 2007-10-15 | HOCKETT WILLIAM A III V. P. of Corp Communications | Sale | −56 | $55.66 | $3K | 2,516 |
| 2007-10-15 | HOCKETT WILLIAM A III V. P. of Corp Communications | Sale | −28 | $55.70 | $2K | 2,488 |
| 2007-10-15 | HOCKETT WILLIAM A III V. P. of Corp Communications | Sale | −245 | $55.13 | $14K | 4,055 |
| 2007-10-15 | HOCKETT WILLIAM A III V. P. of Corp Communications | Sale | −70 | $55.14 | $4K | 3,985 |
| 2007-10-15 | HOCKETT WILLIAM A III V. P. of Corp Communications | Sale | −43 | $55.15 | $2K | 3,942 |
| 2007-10-15 | HOCKETT WILLIAM A III V. P. of Corp Communications | Sale | −65 | $55.17 | $4K | 3,877 |
| 2007-10-15 | HOCKETT WILLIAM A III V. P. of Corp Communications | Sale | −14 | $55.18 | $773 | 3,863 |
| 2007-10-15 | HOCKETT WILLIAM A III V. P. of Corp Communications | Sale | −56 | $55.19 | $3K | 3,807 |
Page 56 of 60 · 1,194 trades